{
    "relation": [
        [
            "Rated by doctors in",
            "General Practice(GP)/Family Practice(FP)",
            "General Internal Medicine-Primary Care(US)",
            "Internal Medicine",
            "Respirology/Pulmonology"
        ],
        [
            "Relevance",
            "*****",
            "*****",
            "*****",
            "*****"
        ],
        [
            "Newsworthiness",
            "*****",
            "*****",
            "******",
            "*****"
        ]
    ],
    "pageTitle": "Citations - COPD",
    "title": "",
    "url": "http://www.clinicalevidence.com/x/systematic-review/1502/citations.html",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 125,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989790.89/warc/CC-MAIN-20150728002309-00119-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 375907291,
    "recordOffset": 375870236,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{423919=\u00a9 BMJ Publishing Group Limited 2015. All rights reserved.}",
    "textBeforeTable": "see ratings (29 July 2015) Canadian Agency for Drugs and Technologies in Health (CADTH). 2010 May;127:1-131. Triple therapy for moderate-to-severe chronic obstructive pulmonary disease. Therapy/Prevention Categories: show all about updates |\u00a0\u00a0disclaimer In-association-with: BMJ Clinical Evidence, in association with the McMaster PLUS surveillance system (for collection and review of the best evidence from the medical literature), has identified the following recent articles: Citations Cancel Save Please do not record person-identifiable clinical or staff information and other sensitive information in this field. <span></span> Notes Remove Cancel Update Please do not record person-identifiable clinical or staff information and other sensitive information in this field. Notes",
    "textAfterTable": "(29 July 2015) Cochrane Database Syst Rev. 2010 May 12;5:CD007891. see ratings Rated by doctors in Relevance Newsworthiness General Practice(GP)/Family Practice(FP) ****** **** General Internal Medicine-Primary Care(US) ****** **** Internal Medicine ******* ***** Respirology/Pulmonology ***** ***** Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. (29 July 2015) Cochrane Database Syst Rev. 2010 May 12;5:CD005074. see ratings Rated by doctors in Relevance Newsworthiness General Practice(GP)/Family Practice(FP) ****** ***** Emergency Medicine ***** **** General Internal Medicine-Primary Care(US) ****** ***** Internal Medicine ****** ***** Respirology/Pulmonology ***** ***** Outpatient pulmonary rehabilitation following acute exacerbations of COPD. (29 July 2015) Thorax. 2010 May;65(5):423-8. see ratings Rated by doctors in Relevance Newsworthiness Physical Medicine and Rehabilitation ***** ***** Respirology/Pulmonology ****** ***** Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}